Physician profile
Edward Roy Berman
NPI 1326082538
$939.43
in general payments reported to CMS, 2019-2025
16 companies · $30.24 in 2025
The $30.24 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2021: $96.79 · 2022: $201 · 2023: $257 · 2024: $215 · 2025: $30.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.36 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $121.43 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $111.14 | 2019-2022 | |
| Baxter Healthcare | $101.10 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Bayer Healthcare Pharmaceuticals INC. | $91.65 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $81.14 | 2023-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.17 | 2022-2024 | Xifaxan |
| Lundbeck LLC | $71.04 | 2023-2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $49.79 | 2021-2023 | Breztri |
| Astellas Pharma US INC | $48.35 | 2022 | |
| Janssen Pharmaceuticals, INC | $40.67 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.00 | 2024 | Ofev, Jardiance |
| Lilly USA, LLC | $29.52 | 2022-2023 | Amyvid |
| Sanofi-Aventis U.S. LLC | $27.78 | 2021 | |
| Eisai INC. | $26.73 | 2024 | |
| Acadia Pharmaceuticals INC | $21.41 | 2023 | Nuplazid |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.